Skip to main content
FinSpry Logo
FinSpry
RAPT logo
RAPT
(NASDAQ)
RAPT Therapeutics, Inc.
$58.01-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

RAPT Therapeutics, Inc. (RAPT) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for RAPT Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 6 professional research analysts

Consensus Rating

Hold
Based on 6 unique analysts
Medium Confidence0

Average Price Target

$58.00
↓ 0.01% Downside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest RAPT Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Thomas Smith
Leerink Partners
HoldDowngrades
$58.00
Etzer Darout
Barclays
HoldDowngrades
$58.00
Kaveri Pohlman
Clear Street
HoldDowngrades
$60.00 → $58.00
Emily Bodnar
HC Wainwright
HoldDowngrades
$58.00
Yaron Werber
TD Cowen
HoldDowngrades
-
Yanan Zhu
Wells Fargo
HoldDowngrades
$58.00

Frequently Asked Questions

What is the analyst consensus rating for RAPT?

The analyst consensus rating for RAPT is "Hold" based on 6 analyst recommendations.

What is the average price target for RAPT?

The average 12-month price target for RAPT is $58.00, representing a downside of 0.0% from the current price of $58.01.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.